Serial measurement of growth-differentiation factor-15 in heart failure: relation to disease severity and prognosis in the Valsartan Heart Failure Trial. [electronic resource]
Producer: 20101029Description: 1387-95 p. digitalISSN:- 1524-4539
- Aged
- Angiotensin II Type 1 Receptor Blockers -- therapeutic use
- Atrial Fibrillation -- complications
- Biomarkers -- blood
- Diabetic Angiopathies -- epidemiology
- Female
- Growth Differentiation Factor 15 -- blood
- Heart Failure -- blood
- Humans
- Hypertension -- complications
- Male
- Middle Aged
- Placebos
- Prognosis
- Regression Analysis
- Risk Assessment
- Risk Factors
- Severity of Illness Index
- Tetrazoles -- therapeutic use
- Valine -- analogs & derivatives
- Valsartan
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
There are no comments on this title.
Log in to your account to post a comment.